Generic manufacturer Teva has received approval from the FDA to launch a generic version of prescription fish oil heart med Lovaza (omega-3-acid ethyl esters). Lovaza is used to lower high triglyceride levels in combination with a healthy diet. Triglycerides are a type of fat found in your blood—similar to cholesterol.
This is good news, and much earlier than generic Lovaza was originally due to be available. The last patents on Lovaza were originally going to expire in 2017. An earlier settlement made a generic possible as early as 2015, but the most recent ruling at the end of 2013 granted Teva and Par Pharmaceuticals permission to launch their generics pending FDA approval.
Teva was the first to file, and will be the first to launch their generic omega-3-acid ethyl esters capsules. They plan to launch immediately, so look for the generic in pharmacies in the next couple of weeks.